PTX:ASX
Prescient Therapeutics Ltd
0,066 A$
0,00%
(0,00) 1D
9 հոկ, 16:10:30 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
0,07 A$
High
0,07 A$
Low
0,06 A$
Mkt. cap
71,18 մլն
Avg. vol.
1,04 մլն
Volume
736,35 հզր
52-wk high
0,12 A$
52-wk low
0,04 A$
EPS
-0,01 A$
Shares outstanding
1,14 մլրդ
No. of employees
3
Open
0,07 A$
High
0,07 A$
Low
0,06 A$
Mkt. cap
71,18 մլն
Avg. vol.
1,04 մլն
Volume
736,35 հզր
52-wk high
0,12 A$
52-wk low
0,04 A$
EPS
-0,01 A$
Shares outstanding
1,14 մլրդ
No. of employees
3
News stories
From web sources and news partners
Simply Wall Street
·
1 ժամ առաջ
SolarEdge Technologies (SEDG) Appoints Gokul Krishnan To Lead North America Growth
The Globe and Mail
·
19 րոպե առաջ
Streamex Receives Nasdaq Notice on Minimum Bid Price
Simply Wall Street
·
59 րոպե առաջ
GLOBALFOUNDRIES (GFS) Unveils FDX Fusion As Dresden And AI Packaging Plans Advance
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 մյս, 1986 թ.
Headquarters-
Sector-
Websiteptxtherapeutics.com